Загрузка...
Erlotinib in the Treatment of Recurrent or Metastatic Cutaneous Squamous Cell Carcinoma: A Single Arm Phase II Clinical Trial
BACKGROUND: Cutaneous squamous cell carcinoma (CSCC) is a very common malignancy. Most patients present with localized disease. Recurrent and metastatic disease is rare, and there is no standard therapy for these patients. These tumors frequently overexpress the epidermal growth factor receptor (EGF...
Сохранить в:
| Опубликовано в: : | Cancer |
|---|---|
| Главные авторы: | , , , , , |
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
2018
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5935588/ https://ncbi.nlm.nih.gov/pubmed/29579331 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/cncr.31346 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|